Home > Compound List > Product Information
Azelaic Acid_Molecular_structure_CAS_123-99-9)
Click picture or here to close

Azelaic Acid

Catalog No. DB00548 Name DrugBank
CAS Number 123-99-9 Website http://www.ualberta.ca/
M. F. C9H16O4 Telephone (780) 492-3111
M. W. 188.22094 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 430

SYNONYMS

IUPAC name
nonanedioic acid
IUPAC Traditional name
azelaic acid
Brand Name
Skinoren
Emerox 1110
Emerox 1144
Emery's L-110
Azelex
Finacea
Finevin
Synonyms
Lepargylic acid
n-Nonanedioic acid
Nonanedioic acid
Heptanedicarboxylic acid
Azalaic Acid
Anchoic acid
Azelainic acid

DATABASE IDS

PubChem CID 2266
CAS Number 123-99-9
PubChem SID 46506284

PROPERTIES

Hydrophobicity(logP) 1.7
Solubility 2400 mg/L (20 oC)

DETAILS

Description (English)
Item Information
Drug Groups approved
Description Azelaic acid is a saturated dicarboxylic acid found naturally in wheat, rye, and barley. It is a natural substance that is produced by Malassezia furfur (also known as Pityrosporum ovale), a yeast that lives on normal skin. It is effective against a number of skin conditions, such as mild to moderate acne, when applied topically in a cream formulation of 20%. It works in part by stopping the growth of skin bacteria that cause acne, and by keeping skin pores clear. Azelaic acid's antimicrobial action may be attributable to inhibition of microbial cellular protein synthesis.
Indication For the topical treatment of mild-to-moderate inflammatory acne vulgaris.
Pharmacology Azelaic acid is a saturated dicarboxylic acid found naturally in wheat, rye, and barley. It is a natural substance that is produced by Malassezia furfur (also known as Pityrosporum ovale), a yeast that lives on normal skin. It is effective against a number of skin conditions, such as mild to moderate acne, when applied topically in a cream formulation of 20%. It works in part by stopping the growth of skin bacteria that cause acne, and by keeping skin pores clear. Azelaic acid's antimicrobial action may be attributable to inhibition of microbial cellular protein synthesis.
Toxicity Oral LD50 in rat: >5 g/kg
Affected Organisms
Various aerobic and anaerobic microorganisms
Biotransformation Mainly excreted unchanged in the urine but undergoes some b-oxidation to shorter chain dicarboxylic acids.
Absorption Approximately 4% of the topically applied azelaic acid is systemically absorbed.
Half Life The observed half-lives in healthy subjects are approximately 45 minutes after oral dosing and 12 hours after topical dosing, indicating percutaneous absorption rate-limited kinetics.
Elimination Azelaic acid is mainly excreted unchanged in the urine, but undergoes some ?-oxidation to shorter chain dicarboxylic acids.
External Links
RxList
PDRhealth
Drugs.com

REFERENCES